Related Experiment Videos
Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin
Q N Luu1, T B Buxton, D R Nelson
1Mercer School of Medicine, Macon, Georgia 31298.
Abstract:
LY146032 and vancomycin were compared as therapeutic agents in the treatment of chronic Staphylococcus aureus osteomyelitis in the rat. Quantitative cultures disclosed that one of 16, none of 16 and two of 17 tibiae were sterile from the control LY146032, and vancomycin groups, respectively. From positive cultures, geometric mean staphylococcal CFU per gram of bone were as follows: control, 5.13 +/- 1.58; LY146032, 5.36 +/- 0.43 (p = 0.57); and vancomycin, 4.33 +/- 1.73 (p = 0.078). Mean gross pathology was decreased significantly in both treatment groups. LY146032 was no more effective than vancomycin in reducing bacterial counts.
Insights
This study compared LY146032 and vancomycin for treating Staphylococcus aureus osteomyelitis in rats. Neither antibiotic demonstrated superior efficacy in reducing bacterial counts or achieving sterile bone cultures.
Area of Science:
- Pharmacology
- Infectious Diseases
- Orthopedics
Background:
- Chronic Staphylococcus aureus osteomyelitis presents a significant therapeutic challenge.
- Limited treatment options necessitate the evaluation of novel antimicrobial agents.
Purpose of the Study:
- To compare the efficacy of LY146032 and vancomycin in treating chronic Staphylococcus aureus osteomyelitis in a rat model.
- To assess the impact of these antibiotics on bacterial load and bone pathology.
Main Methods:
- A rat model of chronic Staphylococcus aureus osteomyelitis was established.
- Animals were treated with LY146032, vancomycin, or served as controls.
- Quantitative cultures of bone tissue and gross pathology assessments were performed.
Main Results:
- Sterility rates were low across all groups: 1/16 (LY146032), 0/16 (control), and 2/17 (vancomycin).
- Bacterial counts (CFU/gram bone) did not differ significantly between LY146032 and control groups (p=0.57).
- Both LY146032 and vancomycin significantly reduced mean gross pathology compared to controls, with no significant difference between the antibiotics.
Conclusions:
- LY146032 demonstrated comparable efficacy to vancomycin in reducing gross pathology but was not superior in reducing bacterial counts in chronic Staphylococcus aureus osteomyelitis.
- Further research is warranted to explore alternative therapeutic strategies for this challenging infection.